The Core Advantage: Features a powerful 2mg Semaglutide formulation by Sematrinity, engineered specifically to deepen clinical satiety, overcome stubborn fat-loss stalls, and streamline daily insulin response
It is also important to be aware of other medications and supplements you are taking, as these may further influence blood sugar control or interact with either Rybelsus or berberine
What began as a once-weekly injectable GLP-1 receptor agonist for type 2 diabetes (Ozempic, approved 2017) has evolved into a multi-formulation, multi-indication therapeutic platform with three commercially marketed products: Ozempic (injectable, diabetes + cardiovascular + CKD), Wegovy (injectable, obesity + cardiovascular + MASH), and Rybelsus (oral tablet, diabetes + cardiovascular + obesity)
MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss
Your doctor can personalise expectations based on your dose and health profile